Osimertinib Then Chemotherapy in EGFR-mutated Lung Cancer with Osimertinib Third-line Rechallenge
Osimertinib Then Chemotherapy in EGFR-mutated Lung Cancer with Osimertinib Third-line Rechallenge
Recruiting · NCT04335292 · Registry updated 2024-10-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Osimertinib Then Chemotherapy in EGFR-mutated Lung Cancer with Osimertinib Third-line Rechallenge | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 2 | 2024-10-22 | NCT04335292 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
| Mark Vincent | 1 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| BC Cancer Agency | Vancouver | Canada | 9 |
| Durham Regional Cancer Centre, Lakeridge Health | Oshawa | Canada | 1 |
| Grand River Regional Cancer Centre | Kitchener | Canada | 4 |
| Hamilton Health Sciences Centre, Juravinski Cancer Centre | Hamilton | Canada | 1 |
| Lions Gate Hospital | Vancouver | Canada | 1 |
| London Regional Cancer Program of the Lawson Health Research Institute | London | Canada | 5 |
| Princess Margaret Hospital | Toronto | Canada | 21 |
| Sunnybrook Research Institute | Toronto | Canada | 36 |
| The Ottawa Hospital | Ottawa | Canada | 47 |
| William Osler Health System | Brampton | Canada | 12 |